Role of molecular markers in the diagnosis and therapy of renal cell carcinoma

Cancer Statistics, 2005

2005 • 5,487 citations

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1999 • 4,973 citations

Hypoxia — a key regulatory factor in tumour growth

2002 • 4,942 citations

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

2003 • 2,723 citations

Prognostic significance of morphologic parameters in renal cell carcinoma

1982 • 2,700 citations

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

1999 • 1,782 citations

Rising Incidence of Renal Cell Cancer in the United States

1999 • 1,593 citations

Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

2000 • 1,527 citations

An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign Score

2002 • 1,073 citations

HIF-1 and tumor progression: pathophysiology and therapeutics

2002 • 1,025 citations

Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System

2001 • 712 citations

A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA

2001 • 706 citations

Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer

2001 • 655 citations

Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma

2002 • 647 citations

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

2003 • 642 citations

Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

2005 • 561 citations

Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification

2001 • 408 citations

Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

2004 • 398 citations

HumanMN/CA9Gene, a Novel Member of the Carbonic Anhydrase Family: Structure and Exon to Protein Domain Relationships

1996 • 383 citations

RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPY

2005 • 373 citations

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

1986 • 358 citations

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

2005 • 333 citations

Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.

1997 • 252 citations

USING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

2005 • 218 citations

Searching for the hereditary causes of renal-cell carcinoma

2004 • 202 citations

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.

1993 • 179 citations

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor

2003 • 179 citations

Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250

2000 • 177 citations

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

2004 • 171 citations

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas

1999 • 161 citations

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

1998 • 157 citations

Surveillance following radical or partial nephrectomy for renal cell carcinoma

2005 • 115 citations

Validation of an Integrated Staging System Toward Improved Prognostication of Patients With Localized Renal Cell Carcinoma in an International Population

2003 • 75 citations

Tissue Array-Based Predictions of Pathobiology, Prognosis, and Response to Treatment for Renal Cell Carcinoma Therapy

2004 • 53 citations

Gene Expression Profiling of Renal Cell Carcinoma

2004 • 38 citations

Advances in immune-based therapies of renal cell carcinoma

2004 • 36 citations

Carbonic Anhydrase IX (CAIX) expression predicts for renal cell cancer (RCC) patient response and survival to IL-2 therapy

2004 • 28 citations

Expression of the vascular endothelial growth factor family in tumor dissemination and disease free survival in clear cell renal cell carcinoma

2005 • 25 citations

Targeting the vascular endothelial growth factor pathway in renal cell carcinoma: A tissue array based analysis

2005 • 23 citations

WHAT NONRESPONSE TO INTRACAVERNOUS INJECTION REALLY INDICATES: A DETERMINATION BY QUANTITATIVE ANALYSIS

2002 • 21 citations

Characterization of the mTOR pathway in renal cell carcinoma and its use in predicting patient selection for agents targeting this pathway

2005 • 20 citations

Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma

2003 • 9 citations

350: Characterization of the MTOR Pathway in Renal Cell Carcinoma and its Use in Predicting Patient Selection for Agents Targeting this Pathway

2005 • 8 citations

1651: Molecular Prognostic Modeling Using Protein Expression Profile in Clear Cell Renal Carcinoma

2004 • 6 citations